Travere Therapeutics, Inc.

NASDAQ:TVTX

14.35 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008
Assets:
Current Assets:
Cash & Cash Equivalents 58.17661.688165.75384.77262.436102.87399.39441.00237.80518.2045.9970.0110.0040.00400.005
Short Term Investments 508.675388.557387.129276.817336.088368.668201.236214.871191.7999.5560.13300000
Cash and Short Term Investments 566.851450.245552.882361.589398.524471.541300.63255.873229.60427.766.130.0110.0040.00400.005
Net Receivables 21.17916.64616.16133.06718.04814.4913.87265.35959.3077.959000000
Inventory 9.416.9227.3137.6086.0825.6195.3512.8262.5360.801000000
Other Current Assets 19.33512.6246.4718.1436.414.0285.9548.29410.4850.8131.3710.0220000
Total Current Assets 616.775486.437582.827410.407429.064495.678325.807332.352301.93237.3347.5010.0330.0040.00400.005
Non-Current Assets:
Property, Plant & Equipment, Net 25.5430.04934.3029.4182.8913.1463.232.5870.4280.6710.1270.0240000
Goodwill 0.80.90.9360.9360.9360.9360.9360.9360.9360.936000000
Intangible Assets 103.69145.038148.435153.189157.2186.691184.817182.043161.53694.26612.5862.1970000
Goodwill and Intangible Assets 104.49145.038148.435154.125158.136187.627185.753182.979162.47295.20112.5862.1970000
Long Term Investments 0000015-16.81-6.42521.245-140.814-2,600.65500000
Tax Assets 0000032.70716.816.42524.328141.1512,600.89900000
Other Non-Current Assets 42.10811.06111.06933.48914.709-24.9985.5567.3641.9951.9280.040.1380000
Total Non-Current Assets 172.138186.148193.806197.032175.736213.482194.539192.93210.46898.13712.9982.3580000
Total Assets 788.913672.585776.633607.439604.8709.16520.346525.282512.4135.47120.4992.3910.0040.00400.005
Liabilities & Equity:
Current Liabilities:
Account Payables 41.67517.2915.14412.13326.6146.95418.9387.5227.6397.1243.5541.0230.0010.00100.001
Short Term Debt 4.9094.4333.9080.3572.61322.45700040.48500.8850.0250.02500.004
Tax Payables 0000000000000000
Deferred Revenue 7.09611.97616.268-0.357-2.61349.69500028.88302.4910000
Other Current Liabilities 124.228108.46488.76880.52768.83525.51566.7375.7478.15931.04631.6561.40.0410.03800.029
Total Current Liabilities 177.908142.163124.08892.6695.449104.62185.66883.26285.798107.53935.215.7990.0670.06400.034
Non-Current Liabilities:
Long Term Debt 377.263403.055258.078215.339204.861195.09145.07744.42243.90243.288000000
Deferred Revenue Non-Current 1.83510.93120.37900-32.707-16.81000000000
Deferred Tax Liabilities Non-Current 22.612000032.70716.816.42524.3280.1412.60100000
Other Non-Current Liabilities 8.48573.58571.97688.22783.29491.19596.46783.40658.40121.75411.90800.02600
Total Non-Current Liabilities 410.195487.571350.433303.566288.155286.286141.544134.253126.63165.1833.6011.90800.02600
Total Liabilities 588.103629.734474.521396.226383.604390.907227.212217.515212.429172.72238.8115.7990.0670.06400.034
Equity:
Preferred Stock 0000000000000000
Common Stock 0.0070.0060.0060.0050.0040.0040.0040.0040.0040.0030.0020.0010000
Retained Earnings -1,125.622-1,014.223-765.966-585.875-416.444-270.017-177.655-113.056-65.153-179.175-67.436-33.612-0.136-0.1210-0.07
Accumulated Other Comprehensive Income/Loss -1.456-2.907-0.562-0.9020.726-1.529-1.015-0.49-0.6824.286-0.1100000
Other Total Stockholders Equity 1,327.8811,059.9751,068.634797.985636.91589.795471.8421.309365.802137.63649.23230.2030.0730.06100.07
Total Shareholders Equity 200.8142.851302.112211.213221.196318.253293.134307.767299.971-37.251-18.312-3.408-0.063-0.0600
Total Equity 200.8142.851302.112211.213221.196318.253293.134307.767299.971-37.251-18.312-3.408-0.063-0.0600
Total Liabilities & Shareholders Equity 788.913672.585776.633607.439604.8709.16520.346525.282512.4135.47120.4992.3910.0040.00400.005